glp-1 constipation class action in kentucky Clinical Recommendations to Manage Gastrointestinal Adverse Events Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus Navigating GLP-1 and Constipation on

And really the most important thing inside reproducibility really is to be able to take this finding or to take the question somewhere else and then be able to reproduce the evidence that is seen in any dataset

Regulation of GLP-1 drugs To ensure ethical pharmaceutical practices in the supply chain of GLP-1, the Drug Controller General of India has intensified its regulatory surveillance against the drugs unauthorised sale and promotion

Pediatr Gastroenterol Hepatol Nutr

Moreover, real-world evidence derived from the US Collaborative Network of TriNetX, which analyzed data from individuals with T2DM aged 18 years who initiated tirzepatide or a GLP-1 RA between June 1, 2022, and June 30, 2023, suggests that tirzepatide reduces the risk of all-cause mortality by 42%, MACE by 20%, and major adverse kidney events by 46% [84]